Citigroup’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.59M Buy
+21,700
New +$4.67M ﹤0.01% 2041
2025
Q1
Sell
-18,000
Closed -$2.13M 5613
2024
Q4
$2.13M Hold
18,000
﹤0.01% 2766
2024
Q3
$1.99M Hold
18,000
﹤0.01% 2671
2024
Q2
$1.77M Hold
18,000
﹤0.01% 2446
2024
Q1
$2.01M Sell
18,000
-17,300
-49% -$1.87M ﹤0.01% 2426
2023
Q4
$3.56M Buy
35,300
+17,300
+96% +$1.72M ﹤0.01% 1822
2023
Q3
$1.56M Sell
18,000
-118,000
-87% -$10.7M ﹤0.01% 2168
2023
Q2
$12.9M Buy
+136,000
New +$11.5M 0.01% 1023
2022
Q4
Sell
-50,000
Closed -$3.33M 5791
2022
Q3
$3.33M Buy
+50,000
New +$3.17M ﹤0.01% 1787
2021
Q1
Sell
-26,700
Closed -$1.43M 6344
2020
Q4
$1.43M Sell
26,700
-16,100
-38% -$835K ﹤0.01% 3190
2020
Q3
$2.01M Sell
42,800
-5,200
-11% -$267K ﹤0.01% 2642
2020
Q2
$2.5M Sell
48,000
-16,400
-25% -$845K ﹤0.01% 2549
2020
Q1
$3.09M Sell
64,400
-28,700
-31% -$1.49M ﹤0.01% 2077
2019
Q4
$4.71M Sell
93,100
-17,700
-16% -$914K ﹤0.01% 2071
2019
Q3
$5.23M Sell
110,800
-33,300
-23% -$1.52M ﹤0.01% 1897
2019
Q2
$6.79M Buy
144,100
+71,400
+98% +$3.29M 0.01% 1714
2019
Q1
$3.5M Sell
72,700
-21,300
-23% -$1.07M ﹤0.01% 2099
2018
Q4
$4.19M Buy
94,000
+21,600
+30% +$1.13M ﹤0.01% 1974
2018
Q3
$3.91M Sell
72,400
-12,600
-15% -$645K ﹤0.01% 2111
2018
Q2
$4.15M Sell
85,000
-2,500
-3% -$142K ﹤0.01% 2014
2018
Q1
$5.49M Buy
87,500
+32,500
+59% +$2.23M ﹤0.01% 1684
2017
Q4
$3.37M Sell
55,000
-18,400
-25% -$1.14M ﹤0.01% 2198
2017
Q3
$4.91M Buy
73,400
+16,200
+28% +$1.15M ﹤0.01% 1784
2017
Q2
$4.46M Buy
57,200
+35,800
+167% +$2.7M ﹤0.01% 1793
2017
Q1
$1.75M Sell
21,400
-40,700
-66% -$3.2M ﹤0.01% 2620
2016
Q4
$4.47M Buy
62,100
+25,600
+70% +$1.85M ﹤0.01% 1957
2016
Q3
$2.84M Sell
36,500
-47,000
-56% -$3.8M ﹤0.01% 2195
2016
Q2
$6.51M Buy
83,500
+33,600
+67% +$2.68M 0.01% 1336
2016
Q1
$4.09M Buy
49,900
+11,200
+29% +$911K ﹤0.01% 1733
2015
Q4
$3.46M Sell
38,700
-4,200
-10% -$357K ﹤0.01% 2036
2015
Q3
$3.3M Buy
42,900
+2,800
+7% +$234K ﹤0.01% 2022
2015
Q2
$3.35M Sell
40,100
-4,700
-10% -$415K ﹤0.01% 2098
2015
Q1
$4.04M Sell
44,800
-6,500
-13% -$560K ﹤0.01% 1908
2014
Q4
$4.14M Sell
51,300
-43,500
-46% -$3.44M ﹤0.01% 1938
2014
Q3
$7.1M Buy
94,800
+19,200
+25% +$1.4M 0.01% 1560
2014
Q2
$5.18M Buy
75,600
+39,500
+109% +$2.69M 0.01% 1767
2014
Q1
$2.53M Sell
36,100
-11,300
-24% -$786K ﹤0.01% 2202
2013
Q4
$3.17M Sell
47,400
-300
-0.6% -$18.3K ﹤0.01% 2181
2013
Q3
$2.49M Sell
47,700
-1,500
-3% -$76.2K ﹤0.01% 2310
2013
Q2
$2.32M Buy
+49,200
New +$2.25M ﹤0.01% 2267

Other funds holding CAH

Citigroup's CAH Position: Q1 2026 in Review

Citigroup reduced its Cardinal Health (CAH) stake by 14% in Q1 2026, selling an estimated $12M and leaving 340,335 shares worth $71.9M. The position accounts for 0.03% of the portfolio, ranked #516.

Citigroup first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $81.3M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Citigroup held 340,335 shares of Cardinal Health worth $71.9M as of Q1 2026.
  • Citigroup sold 55,503 Cardinal Health shares in Q1 2026, an estimated $12M.
  • Cardinal Health made up 0.03% of Citigroup's portfolio in Q1 2026, its #516 holding.
  • Citigroup first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Cardinal Health position peaked at $81.3M in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.